“products with health warnings were rated significantly less appealing and more harmful than those with no warning,” note authors of the study published online this week in preventive medicine.
advertisement
the recommendation is in line with a u of w study published in 2019.
in another review by david hammond, a co-author of the most recent study, hammond identified a need for “regulated cannabis markets to develop more effective packaging and labelling standards to allow consumers to effectively titrate their thc intake, with the goal of promoting lower-risk cannabis use.”
advertisement
canada’s cannabis act and cannabis regulations detail prohibitions around marijuana product packaging and labelling . these products cannot be appealing to young people, include any testimonial or endorsement, depict a person, character or animal, or evoke an emotion regarding a way of life that includes glamour, recreation, excitement, vitality, risk or daring.
an article earlier this year in the conversation noted that cannabis producers should have more packaging and labelling flexibility. “it would also better support federal cannabis policy, as existing rules inadvertently encourage higher potency while sidelining other aspects of quality .”
advertisement
u.s.-based smithers, a multinational provider of testing, consulting, information, and compliance services, forecasts the global cannabis packaging market value will reach us$1.6 billion ($2 billion) in 2024.